
Glinem M 1mg/500mg Tablet SR
Marketer
Nemi Pharmaceuticles
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glinem M 1mg/500mg Tablet SR
Glinem M 1mg/500mg SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This dual-action treatment effectively manages blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician, subject to adjustment based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is a component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headaches, and tremors. Learn to recognize and manage these symptoms; regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Primary Ingredients of Glinem M 1mg/500mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Glinem M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glinem M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glinem M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Glinem M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glinem M 1mg/500mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glinem M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking. Administer this extended-release tablet with a meal.
How Glinem M 1mg/500mg Tablet SR works:
Glinem M SR tablets (1mg glimepiride/500mg metformin) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glinem M 1mg/500mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Glinem M 1mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Physician consultation is advised.
Breast feedingUNSAFE
Extended-release Glinem M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glinem M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glinem M 1mg/500mg Tablet SR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Glinem M 1mg/500mg Tablet SR cautiously, as dose modification may be necessary. Consult a physician for guidance. A low initial dose is typically recommended for those with mild to moderate liver disease; however, it's contraindicated in patients with severe liver dysfunction.
What if you forget to take Glinem M 1mg/500mg Tablet SR :
Should you forget a Glinem M 1mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glinem M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
